Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q2 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Pyxis Oncology Inc. (PYXS) PT Raised to $8 at H.C. Wainwright
• Goldman, BofA vie to manage Anthropic employee wealth post-IPO - report